Advances in psychiatric genomics have consistently revealed association of schizophrenia, bipolar disorder and related neurodevelopmental disorders with genetic variation in VGCCs and in particular CACNA1C. Understanding the impact of genetic variation in the associated loci is critical for gaining mechanistic insight into these conditions and development of new therapies. This evidence concerns the gene CACNA1C and bipolar disorder.